● Recruiting

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Condition: Rectal Cancer · Sponsor: Virginia Commonwealth University

PhasePhase 2

Planned participants64

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is phase 2 trial of neoadjuvant therapy and short-course radiotherapy in resectable rectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Massey IIT Research Operations, RN · 804-628-6430 · masseyepd@vcu.edu

Always discuss trial participation with your own doctor first.

Locations (4)

Virginia Cancer Institute	Richmond, Virginia, United States	Recruiting
Virginia Commonwealth University Massey Cancer Center	Richmond, Virginia, United States	Recruiting
VCU Community Memorial Healthcenter	South Hill, Virginia, United States	Recruiting
VCU Health Tappahannock Hospital	Tappahannock, Virginia, United States	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04643366